期刊文献+

乳腺癌肿瘤代谢异质性与p53基因表达和淋巴结转移相关性的研究 被引量:8

Correlation of intratumor metabolic heterogeneity with p53 expression and lymph node metastasis in breast cancer
下载PDF
导出
摘要 目的:分析乳腺癌肿瘤代谢异质性与p53基因表达和乳腺癌淋巴结转移的关系。方法:选取接受18 F-FDG PET/CT检查的原发性乳腺癌患者34例,分别测定每例患者原发灶的肿瘤代谢异质因子(heterogeneity factor,HF),同时将HF与p53基因表达和淋巴结转移进行相关性分析,采用受试者工作特性曲线(area under receiver operating characteristic curve,ROC)分析HF对p53基因突变及淋巴结转移的诊断效能。结果:HF与乳腺癌p53基因表达呈弱相关性( P <0.05);HF与淋巴结转移无相关性( P >0.05)。结论:HF与乳腺癌p53基因表达具有相关性,HF对预测p53基因表达具有一定意义,然而,HF不能预测乳腺癌是否有淋巴结转移。 Objective:To evaluate the relationship between tumor heterogeneity factor and p53 and study the correlation of tumor heterogeneity factor and lymph node metastasis. Methods:Thirty four patients with primary breast cancer who underwent PET-CT examination were selected.The HF value of each patient was calculated by a computer.We analyzed the correlation between HF and p53 and studied HF and lymph node metastasis respectively. Results:There was a significant positive correlation between HF and p53 in breast cancer( P <0.05).However,HF was not associated with lymph node metastasis( P >0.05). Conclusion:HF is associated with p53 in breast cancer.So,computing HF helps the prediction of p53.HF can provide reference for tumor diagnosis,prognosis estimation and clinical guidance.However,HF cannot predict whether breast cancer patients have lymph node metastasis.
作者 崔婷婷 李红 张倩 辛军 Cui Tingting;Li Hong;Zhang Qian;Xin Jun(Radiology Department,Shengjing Hospital of China Medical University,Liaoning Shenyang110004,China;GE Medical Systems Trade Development(Shanghai) Co.,LTD,Shanghai 201203,China.)
出处 《现代肿瘤医学》 CAS 2019年第15期2670-2673,共4页 Journal of Modern Oncology
关键词 乳腺癌 HF P53 淋巴结转移 breast cancer HF p53 lymph node metastasis
  • 相关文献

参考文献2

二级参考文献17

  • 1李宝江,朱志华,王军业,侯景辉,赵进明,张蓬原,姚广裕,王曦,龙浩,杨名添,戎铁.Ki67、P53、VEGF和C-erbB-2在乳腺癌组织中表达的相关性研究及其临床意义[J].癌症,2004,23(10):1176-1179. 被引量:126
  • 2王黎明,徐世文,龚晓萌.cerbB-2、Bcl-2、Ki-67在乳腺癌中的表达及临床意义[J].现代肿瘤医学,2006,14(10):1217-1219. 被引量:4
  • 3刘华,施威,吴德敬.乳腺癌组织p53、bcl-2、PCNA和雌激素水平与临床病理及预后的关系[J].临床肿瘤学杂志,2006,11(12):898-900. 被引量:6
  • 4Jemal A,Bray F,Center MM. Golbal cancer statistic[J].{H}CA-A Cancer Journal for Clinicians,2011,(02):69-90.
  • 5Kamangar F,Dores GM,Anderson WF. Patterns of cancer incidence,mortality,and prevalence across five continents:defining priorities to reduce cancer disparities in different geographic regions of the world[J].{H}Journal of Clinical Oncology,2006,(14):2137-2150.
  • 6Panahi M,Saki N,Ashourzadeh S. Expressional correlation of human epidermal growth factor receptor 2,estrogen/progesterone receptor and protein 53 in breast cancer[J].{H}Asian Pacific Journal of Cancer Prev,2013,(06):3699-3703.
  • 7Skálová A,Sima R,Vanecek T. Acinic cell carcinoma with high-grade transformation:a report of 9 cases with immunohistochemical study and analysis of TP53 and HER-2/neu genes[J].{H}American Journal of Surgical Pathology,2009,(08):1137-1145.
  • 8Milde-Langosch K,Karn T,Müller V. Validity of the proliferation markers Ki67,TOP2A,and RacGAP1 in molecular subgroups of breast cancer[J].{H}Breast Cancer Research and Treatment,2013,(01):57-67.
  • 9Yerushalmi R,Woods R,Ravdin PM. Ki67 in breast cancer:prognostic and predictive potential[J].{H}LANCET ONCOLOGY,2010,(02):174-183.
  • 10Ferguson NL,Bell J,Heidel R. Prognostic value of breast cancer subtypes,Ki-67 proliferation index,age,and pathologic tumor characteristics on breast cancer survival in Caucasian women[J].{H}BREAST JOURNAL,2013,(01):22-30.

共引文献14

同被引文献75

引证文献8

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部